Healthcare -
Biotechnology - NASDAQ - DE
$ 3.47
-3.17 %
$ 781 M
Market Cap
6.59
P/E
CVAC - REVENUE
Revenue CVAC - CureVac N.V.
535 M
LAST VALUE
181.74%
2 YEAR CAGR
98.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR